This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_NSCLC_SQUAM_EXALLC for full statistics.
Non-small cell lung cancer, squamous
C3_NSCLC_SQUAM
non-small cell lung carcinoma: A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
1956 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1956 |
4. Check minimum number of eventsNone |
1956 |
5. Include endpoints |
1956 |
6. Filter based on genotype QC (FinnGen only) |
1956 |
Control definitions (FinnGen only)
- Control conditions
- not HLP_C3_NSCLC_SQUAM
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Non-small cell lung cancer, squamous
based on the number of shared cases.
Similar with more cases:
- Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)
- Non-small cell lung cancer, squamous, helper endpoint
- Non-small cell lung cancer
- Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of bronchus and lung
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1956 | 283 | 1673 |
| Unadjusted period prevalence (%) | 0.64 | 0.10 | 0.74 |
| Median age at first event (years) | 71.76 | 69.71 | 72.10 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1849
- Matched controls
- 18491
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
9532.4
323.0
981
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
12.1
323.0
941
1453
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
323.0
348
*
130
Kela drug reimbursment
Malignant tumour
12.0
323.0
790
1084
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
232.9
323.0
670
45
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
196.9
323.0
503
35
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
22.4
323.0
591
380
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
323.0
426
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
13.9
323.0
856
1078
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
24.8
318.8
464
246
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
23.3
221.2
326
168
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
26.1
187.6
266
118
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
129.5
185.3
197
17
GDC00
NOMESCO Finland
Lobectomy of lung
56.3
184.6
219
44
L01CA04
ATC
vinorelbine; systemic
57.9
155.0
183
35
H02AB02
ATC
dexamethasone; systemic
6.3
147.7
439
865
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.0
139.5
710
2469
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
22.9
134.7
198
96
A03FA01
ATC
metoclopramide; systemic, rectal
4.1
131.3
632
2067
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
54.0
128.9
154
31
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
138.5
121.8
129
10
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
23.7
116.4
169
78
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
71.0
110.2
126
19
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
12.2
105.0
198
180
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
23.0
97.8
143
67
WF004
NOMESCO Finland
Palliative radiotherapy
12.6
96.6
179
156
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.2
92.3
268
491
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
24.7
90.2
129
56
A04AA01
ATC
ondansetron; systemic, rectal
6.3
88.5
253
453
1623A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA EPIDERMOIDES]
100.1
86.8
95
10
N02AA05
ATC
oxycodone; systemic
3.2
83.0
535
2081
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
84.0
78.8
88
11
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
11.1
75.9
149
145
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.3
73.6
187
282
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
12.8
73.4
134
112
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
10.3
70.5
144
151
Z51.5
ICD-10 Finland
Palliative care
4.3
70.4
286
750
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
10.6
65.5
131
132
R03BB04
ATC
tiotropium bromide; inhalant
3.0
64.5
453
1822
R04.2
ICD-10 Finland
Haemoptysis
5.4
63.5
204
415
GDD00
NOMESCO Finland
Pneumonectomy
117.6
63.3
68
6
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
7.9
62.0
148
202
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
26.6
60.4
84
33
GD1AD
NOMESCO Finland
Thorax CT examination
5.4
60.1
191
383
R84
ICPC
Malignant neoplasm bronchus/lung
32.5
59.1
78
25
TGD00
NOMESCO Finland
Needle biopsy of lung
46.0
58.0
71
16
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
13.3
57.1
102
81
WF002
NOMESCO Finland
Radical radiotherapy
4.6
55.8
210
505
H02AB06
ATC
prednisolone; systemic
2.2
55.5
971
6222
5826
FHL
Lobectomy or bilobectomy
30.8
55.4
74
25
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
33.5
54.3
71
22
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.7
51.7
157
297
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
22.0
51.7
76
36
8070/3-C34.0
ICD-O-3
Squamous cell carcinoma, NOS, of main bronchus
+∞
51.3
49
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
51.2
827
5052
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
15.3
50.8
85
58
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
17.2
50.7
81
49
A04AA55
ATC
palonosetron, combinations; systemic
12.2
50.2
93
80
1625A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA EPIDERMOIDES]
133.6
49.0
52
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
30.1
47.7
64
22
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
47.0
258
855
A98
ICPC
Health maint/preventive medicine
0.5
42.8
815
11243
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.7
41.2
329
1391
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.6
37.8
66
50
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
9.9
37.7
77
81
8070/3-C34.2
ICD-O-3
Squamous cell carcinoma, NOS, of middle lobe, lung
+∞
37.6
36
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.8
37.5
170
481
R03AC02
ATC
salbutamol; inhalant
1.9
37.0
842
5649
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.4
34.6
176
547
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.0
34.4
147
395
J01MA14
ATC
moxifloxacin; systemic
2.8
34.0
243
953
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
13.6
32.8
57
43
WZC30
NOMESCO Finland
Teaching
2.6
31.9
262
1111
5828
FHL
Pneumectomy
89.2
31.8
35
*
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
25.0
31.5
44
18
N07BA03
ATC
varenicline; oral
5.9
31.2
90
160
A04AA02
ATC
granisetron; systemic, transdermal
3.8
30.8
139
391
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.2
29.9
117
290
JN4BD
NOMESCO Finland
Extensive body CT
2.4
29.8
277
1256
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.0
29.3
183
658
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.5
28.6
87
165
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
14.5
28.5
48
34
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
14.5
28.5
48
34
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
28.1
438
2496
J01MA12
ATC
levofloxacin; systemic
2.0
28.0
457
2652
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.5
27.8
230
978
N06DX01
ATC
memantine; oral
0.2
27.2
20
1179
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
6.2
26.8
73
121
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
28.2
26.7
36
13
1240
FHL
Bronchoscopy
5.2
26.6
84
167
GDC10
NOMESCO Finland
Bilobectomy of lung
52.5
26.2
31
6
GEA00
NOMESCO Finland
Mediastinoscopy
18.6
26.2
40
22
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
26.0
476
2867
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.1
25.9
345
1841
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
8.9
24.8
53
61
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
25.8
24.0
33
13
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.5
23.9
262
4480
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.9
23.5
99
263
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
11.9
23.0
42
36
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
30.5
22.8
30
10
1622A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA EPIDERMOIDES]
232.7
22.7
23
*
1628A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA EPIDERMOIDES]
232.7
22.7
23
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
22.6
312
1678
N02AX02
ATC
tramadol; systemic, rectal
1.7
22.6
767
5540
R03BB01
ATC
ipratropium bromide; inhalant
2.4
22.6
203
900
B02AA02
ATC
tranexamic acid; systemic
2.3
22.2
211
961
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
7.0
22.1
55
81
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.9
22.0
94
253
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.2
22.0
22
1072
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
21.9
413
6135
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
14.7
21.7
36
25
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.4
21.5
115
2503
XG410
NOMESCO Finland
Flow-volume spirometry
3.1
20.8
117
389
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
4.3
20.7
77
183
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
20.5
376
5649
SAA02
NOMESCO Finland
Basic examination of mouth
0.6
20.4
329
5104
P20
ICPC
Memory disturbance
0.4
19.9
79
1933
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
19.8
788
5873
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
19.5
28
1108
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
6.5
18.9
49
77
I10
ICD-10 Finland
Essential (primary) hypertension
0.6
18.8
716
9187
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.5
18.7
189
3348
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.9
18.7
62
131
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
23.9
18.6
26
11
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
12.4
18.6
33
27
GDC20
NOMESCO Finland
Lobectomy of lung and sleeve resection of bronchus
191.8
18.6
19
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.8
18.6
80
218
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.6
18.4
272
4343
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.5
18.0
155
2884
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
33.2
18.0
23
7
GD002
NOMESCO Finland
Radical radiotherapy of trachea, bronchi and lungs
53.0
18.0
21
*
J01AA02
ATC
doxycycline; systemic
1.6
18.0
1264
10700
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.9
17.6
73
193
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
17.1
17.4
27
16
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
16.1
17.0
27
17
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.5
16.9
115
2315
GCA05
NOMESCO Finland
Bronchoscopic laser therapy of lesion of bronchus
63.9
16.7
19
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.2
16.7
182
881
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
7.5
16.7
39
53
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.7
16.7
73
202
WX250
NOMESCO Finland
Intercostal blockade
23.3
16.4
23
10
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
9.1
16.4
34
38
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.5
16.4
123
2395
Z72.0
ICD-10 Finland
Tobacco use
4.9
16.4
53
110
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.0
16.3
96
332
N02AA01
ATC
morphine; systemic, rectal
3.7
16.2
72
202
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
16.2
210
1096
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.4
16.2
58
134
ZX120
NOMESCO Finland
Intravenous
2.1
16.1
188
937
XKD00
NOMESCO Finland
Uroflowmetry
0.5
15.9
193
3261
N06DA03
ATC
rivastigmine; oral, transdermal
0.1
15.7
9
631
K02.1
ICD-10 Finland
Caries of dentine
0.6
15.6
306
4582
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.2
15.5
58
140
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.7
15.4
44
79
F03
ICD-10 Finland
Unspecified dementia
0.3
15.2
24
901
ZX095
NOMESCO Finland
Combined chemoradiotherapy
12.5
14.9
26
21
JN4AD
NOMESCO Finland
Body CT examination
2.2
14.8
157
751
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.6
14.5
312
4594
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
15.5
14.4
23
15
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.0
14.4
84
290
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.4
14.3
70
213
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
14.3
334
2127
1CD01
NOMESCO Finland
NA
19.3
14.2
21
11
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
13.5
14.2
24
18
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.4
14.0
121
524
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.0
13.9
55
140
A04AD12
ATC
aprepitant; systemic
5.7
13.9
39
69
C10AA05
ATC
atorvastatin; oral
0.6
13.9
387
5397
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
13.7
149
719
R03AK07
ATC
formoterol and budesonide; inhalant
1.8
13.7
254
1502
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.6
13.7
178
2966
N06DA02
ATC
donepezil; oral
0.3
13.7
30
958
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.5
13.6
116
2180
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
13.3
634
4798
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
8.2
13.3
29
36
K03.64
ICD-10 Finland
Dental calculus supragingival
0.4
13.2
72
1565
L15
ICPC
Knee symptom/complaint
0.4
13.1
74
1593
R03DA04
ATC
theophylline; systemic, rectal
1.9
13.1
209
1177
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.6
12.9
158
2682
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
11.6
12.8
23
20
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
12.8
15
668
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.6
12.7
267
3968
A06AC01
ATC
ispaghula (psylla seeds); oral
0.6
12.6
162
2712
L57.0
ICD-10 Finland
Actinic keratosis
0.4
12.6
56
1313
KMAK
NOMESCO Finland
NA
0.6
12.6
285
4167
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
24.5
12.5
17
7
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.7
12.3
85
326
PJD99
NOMESCO Finland
Excision of other lymph nodes
37.8
12.2
15
*
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
5.0
12.0
38
78
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
10.1
12.0
23
23
ZX050
NOMESCO Finland
Stereotactic radiotherapy
6.3
12.0
31
50
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
5.6
11.9
34
62
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.1
11.9
7
479
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
4.9
11.9
38
79
H81
ICPC
Excessive ear wax
0.5
11.9
114
2071
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.4
11.8
63
1384
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.4
11.8
65
1412
L03AA13
ATC
pegfilgrastim; parenteral
3.1
11.7
63
207
I50.9
ICD-10 Finland
Heart failure, unspecified
0.6
11.7
207
3207
Z01.2
ICD-10 Finland
Dental examination
0.6
11.6
183
2914
C10AA01
ATC
simvastatin; oral
0.7
11.6
612
7652
J93.8
ICD-10 Finland
Other pneumothorax
10.1
11.5
22
22
1629A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA EPIDERMOIDES]
120.7
11.4
12
*
J01FA06
ATC
roxithromycin; oral
1.5
11.4
600
4599
SPAT1301
SPAT
No procedures
0.6
11.4
253
3729
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
11.4
146
2448
VALMI
NOMESCO Finland
NA
0.5
11.3
78
1570
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
7.0
11.3
27
39
A02BX02
ATC
sucralfate; oral
2.3
11.3
108
493
J43.9
ICD-10 Finland
Emphysema, unspecified
3.0
11.2
64
217
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.1
11.2
*
339
1BC05
NOMESCO Finland
NA
25.2
11.1
15
6
TGC00
NOMESCO Finland
Bronchial lavation
3.0
11.0
61
205
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
5.6
11.0
31
56
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
0.4
11.0
40
1018
G30.8
ICD-10 Finland
Other Alzheimer disease
0.1
11.0
*
362
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
0.5
11.0
109
1963
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
0.6
10.8
134
2273
191
Kela drug reimbursment
Erlotinib
9.6
10.7
21
22
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
28.2
10.7
14
5
GDA10
NOMESCO Finland
Biopsy of lung
13.0
10.6
18
14
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.9
10.6
64
228
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.5
10.6
79
1553
116
Kela drug reimbursment
Prostate cancer
0.5
10.6
76
1514
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
10.6
234
3457
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
3.5
10.5
48
140
S18
ICPC
Laceration/cut
0.7
10.5
344
4700
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.5
10.4
36
82
1624A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA EPIDERMOIDES]
110.6
10.4
11
*
8070/3-C34.8
ICD-O-3
Squamous cell carcinoma, NOS, of overlapping lesion of lung
+∞
10.4
10
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.2
10.4
108
514
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
6.8
10.4
25
37
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
0.7
10.3
388
5171
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
10.6
10.3
19
18
GAA31
NOMESCO Finland
Thoracoscopy
8.8
10.3
21
24
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
18.9
10.3
15
8
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.5
10.2
102
1835
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
10.2
389
5176
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.3
10.2
21
689
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.7
10.1
329
4509
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.6
10.0
212
3168
TGA30
NOMESCO Finland
Thoracocentesis
4.4
10.0
35
81
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
10.1
10.0
19
19
R85
ICPC
Malignant neopl respiratory other
14.7
10.0
16
11
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
40.3
10.0
12
*
C10AA07
ATC
rosuvastatin; oral
0.6
9.9
154
2467
M01AX05
ATC
glucosamine; oral
0.6
9.9
139
2281
SPAT1053
SPAT
Memory test
0.6
9.9
147
2381
D01AE16
ATC
amorolfine; topical
0.4
9.8
52
1148
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
8.2
9.8
21
26
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
4.0
9.8
38
97
A06AH03
ATC
naloxegol; oral
4.3
9.8
35
83
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.7
9.6
64
242
J86.9
ICD-10 Finland
Pyothorax without fistula
4.2
9.6
35
85
7866A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Swelling, mass, or lump in chest
10.1
9.5
18
18
GD004
NOMESCO Finland
Palliative radiotherapy of trachea, bronchi and lungs
15.1
9.5
15
10
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.7
9.5
355
4750
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.7
9.5
295
4081
DFF00
NOMESCO Finland
Pure tone audiometry
0.4
9.4
32
836
H13
ICPC
Plugged feeling ear
0.6
9.4
127
2107
XG460
NOMESCO Finland
Short time oxymetry
2.7
9.4
63
238
GDC13
NOMESCO Finland
Extended lobectomy or bilobectomy of lung
+∞
9.4
9
*
R24
ICPC
Haemoptysis
6.2
9.4
24
39
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
21.8
9.3
13
6
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.7
9.3
449
5764
SPAT1153
SPAT
Removal of sutures
0.7
9.3
240
3446
D82
ICPC
Teeth/gum disease
0.6
9.3
141
2273
M01AH05
ATC
etoricoxib; oral
0.7
9.1
396
5177
A02BA02
ATC
ranitidine; systemic
1.5
9.0
378
2749
R95
ICPC
Chron obstructive pulmonary disease
2.5
9.0
71
296
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.3
8.9
26
50
G04CA01
ATC
alfuzosin; oral
0.6
8.9
149
2352
H02
ICPC
Hearing complaint
0.5
8.8
74
1405
D19
ICPC
Teeth/gum symptom/complaint
0.5
8.8
89
1597
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
0.5
8.8
89
1598
R53
ICD-10 Finland
Malaise and fatigue
0.6
8.8
168
2567
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.3
8.8
76
334
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.4
8.7
48
1044
C34.95
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other non-microcellular carcinoma
50.2
8.7
10
*
-1
NOMESCO Finland
NA
0.6
8.7
151
2360
XJH00
NOMESCO Finland
Transanal ultrasonography
0.5
8.7
70
1339
G04BD12
ATC
mirabegron; oral
0.5
8.6
50
1066
N02BE01
ATC
paracetamol; systemic, rectal
0.7
8.6
1036
11671
SPAT1043
SPAT
Audiometry
0.5
8.5
56
1145
L82
ICD-10 Finland
Seborrhoeic keratosis
0.5
8.4
77
1419
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
0.5
8.3
91
1598
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.0
8.3
46
157
UKC02
NOMESCO Finland
Cystoscopy
0.7
8.3
206
2984
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
4.6
8.3
27
59
R05CB01
ATC
acetylcysteine; inhalant, oral
2.6
8.3
60
239
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
9.5
8.3
16
17
C08CA01
ATC
amlodipine; oral
0.7
8.2
399
5138
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.5
8.2
50
1047
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
5.2
8.2
24
47
WW200
SPAT
NA
0.3
8.1
17
552
G04CA02
ATC
tamsulosin; oral
0.7
8.1
483
6024
A04AA03
ATC
tropisetron; systemic
17.2
8.1
12
7
R33
ICD-10 Finland
Retention of urine
0.6
8.1
101
1711
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.5
8.1
77
1402
F01.9
ICD-10 Finland
Vascular dementia, unspecified
0.1
8.0
*
282
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
0.5
8.0
51
1055
R06.0
ICD-10 Finland
Dyspnoea
1.4
8.0
420
3184
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
7.9
108
1788
1440
FHL
Mediastinoscopy
13.1
7.9
13
10
L01XE03
ATC
[U] erlotinib; oral
7.8
7.9
17
22
N02AC04
ATC
dextropropoxyphene; oral
1.9
7.9
110
591
J01MA02
ATC
ciprofloxacin; systemic
0.7
7.9
459
5753
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
0.7
7.8
210
2999
UGC02
NOMESCO Finland
Rigid bronchoscopy
8.5
7.8
16
19
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.6
7.8
87
1516
WX330
NOMESCO Finland
Paravertebral ansthesia
45.2
7.7
9
*
S82
ICPC
Naevus/mole
0.4
7.7
41
899
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
5.3
7.7
22
42
114
Kela drug reimbursment
Glaucoma
0.5
7.7
73
1333
R03AL05
ATC
formoterol and aclidinium bromide; inhalant
7.4
7.7
17
23
D01BA02
ATC
terbinafine; oral; topical
0.7
7.7
189
2748
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
3.6
7.7
32
89
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
6.7
7.6
18
27
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.5
7.6
51
1035
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.3
7.6
36
111
JN5AP
NOMESCO Finland
Total body PET (1 picture)
25.1
7.6
10
*
5188X
ICD-9 Finland
Other diseases of lung
4.5
7.6
25
56
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
3.9
7.6
29
75
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.4
7.4
357
2655
SDA02
NOMESCO Finland
Parodonthologic therapy
0.6
7.4
152
2292
I50.0
ICD-10 Finland
Congestive heart failure
0.6
7.3
101
1673
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.6
7.3
138
2120
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
10.9
7.3
13
12
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.4
7.3
57
238
L03AA14
ATC
lipegfilgrastim; parenteral
4.5
7.3
24
54
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
7.3
7.2
16
22
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
0.6
7.2
139
2127
205
Kela drug reimbursment
Chronic hypertension
0.7
7.2
442
5509
P70
ICPC
Dementia
0.2
7.1
5
306
1625X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,EI HIST/SYTOL DG]
20.1
7.1
10
5
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
20.1
7.1
10
5
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
0.4
7.1
23
615
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
7.0
258
3485
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
0.6
7.0
83
1428
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.0
7.0
38
130
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.4
6.9
28
681
C34.13
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma
13.8
6.9
11
8
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
0.3
6.9
17
509
J01DB01
ATC
cefalexin; oral
0.8
6.9
910
10288
C09AA02
ATC
enalapril; systemic
0.7
6.8
246
3337
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
2.9
6.8
39
135
DFF15
NOMESCO Finland
Speech audiometry
0.3
6.8
14
457
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
1.9
6.8
96
522
GDB20
NOMESCO Finland
Segmental resection of lung
40.2
6.8
8
*
S29
ICPC
Skin symptom/complaint other
0.6
6.8
93
1541
N03AX16
ATC
pregabalin; oral
1.4
6.7
300
2201
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
0.1
6.7
*
248
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
0.6
6.7
104
1671
WX734
NOMESCO Finland
JET-ventilation
22.6
6.7
9
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
0.4
6.6
31
712
UJF32
NOMESCO Finland
Coloscopy
0.7
6.6
233
3179
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.2
6.6
32
101
L02AE02
ATC
leuprorelin; implant, parenteral
0.5
6.6
48
951
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.5
6.6
28
80
N05AX08
ATC
risperidone; systemic
0.5
6.6
55
1044
GAC00
NOMESCO Finland
Biopsy of pleura
4.6
6.6
21
46
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.8
6.6
40
147
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
12.3
6.6
11
9
SFA40
NOMESCO Finland
Replacement of krone of tooth
0.6
6.5
114
1786
C09CA01
ATC
losartan; oral
0.7
6.5
205
2854
C09CA06
ATC
candesartan; oral
0.6
6.5
131
1986
DAX08
NOMESCO Finland
Fitting of hearing aid
0.3
6.5
16
480
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
6.5
354
2691
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
0.2
6.5
9
359
WX600
NOMESCO Finland
Single shot through catheter
4.5
6.5
21
47
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
5.3
6.5
18
34
155
Kela drug reimbursment
Afatinib and gefitinib
70.1
6.4
7
*
S01ED51
ATC
timolol, combinations; ophthalmic
0.5
6.4
53
1007
H91.1
ICD-10 Finland
Presbycusis
0.5
6.4
50
966
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.6
6.3
90
1477
J01DA01
ATC
[U] cefalexin; systemic
1.3
6.3
964
8498
M79.6
ICD-10 Finland
Pain in limb
0.7
6.3
239
3220
I25
ICD-10 Finland
Chronic ischaemic heart disease
0.4
6.2
31
694
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.1
6.2
68
336
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.5
6.2
44
177
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
3.2
6.1
30
96
B01AA03
ATC
warfarin; systemic
0.7
6.1
364
4583
SPAT1325
SPAT
Vaccination
0.7
6.1
351
4441
N06DA04
ATC
galantamine; oral
0.2
6.1
6
292
N05BA04
ATC
oxazepam; oral
1.4
6.0
349
2675
R31
ICD-10 Finland
Unspecified haematuria
0.6
6.0
117
1791
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.9
6.0
80
427
SPAT1097
SPAT
Recording of ECG
0.6
6.0
110
1701
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
298
204
17.05
307.65
1.2
1.1
—
—
—
0
0
248
371
7.51
161.35
1.3
1.5
—
—
—
0
0
255
627
4.53
95.81
2.1
2.6
—
—
—
0
0
691
10958
0.43
67.77
6.0
6.8
42.6
41.6
mmol/mol
1.70
604
9822
743
11316
0.45
63.02
4.1
5.4
2.4
2.4
mmol/l
0.01
627
10062
132
265
5.27
62.70
1.3
1.3
—
—
—
0
0
706
10946
0.44
62.54
3.7
4.7
4.2
4.2
mmol/l
0.21
606
9788
694
10802
0.45
61.65
3.7
4.7
1.3
1.4
mmol/l
2.39
585
9561
681
10465
0.46
55.13
3.4
4.2
1.3
1.3
mmol/l
1.57
571
9190
779
11315
0.48
52.07
5.3
5.1
6.2
6.2
mmol/l
0.46
674
9929
936
12691
0.50
49.34
43.0
27.7
8.5
7.1
e9/l
22.55
906
12123
460
7971
0.45
49.24
4.0
5.5
2.4
5.0
ug/l
4.22
386
6944
936
12686
0.50
49.18
43.2
27.9
125.1
132.0
g/l
32.14
915
12312
936
12685
0.50
49.15
42.9
27.7
4.2
4.4
e12/l
12.19
903
12115
936
12682
0.50
49.05
43.0
27.7
278.8
229.8
e9/l
47.61
908
12177
935
12540
0.51
44.98
31.7
23.1
4.0
4.0
mmol/l
0.49
912
12081
935
12526
0.51
44.56
31.9
22.9
138.4
139.6
mmol/l
28.01
913
12088
914
12289
0.52
43.31
35.4
22.6
81.5
92.7
umol/l
20.77
914
12282
914
12231
0.53
41.66
18.1
11.1
22.3
25.0
u/l
2.94
897
11570
354
6407
0.45
39.57
3.8
4.8
21.6
22.2
%
0.33
165
3411
238
973
2.65
38.54
6.7
2.0
427.6
374.4
nmol/l
3.04
231
868
732
10348
0.53
38.13
5.8
4.3
2.0
2.1
mu/l
0.53
656
9054
79
165
4.95
35.75
1.3
1.2
14.2
8.5
u/l
2.53
65
131
794
10817
0.55
34.69
28.6
18.3
77.4
69.4
ml/min/173m2
25.59
716
9013
355
6133
0.49
33.02
1.8
2.2
86.4
90.6
pmol/l
1.08
207
3351
27
16
17.10
32.43
1.0
1.1
—
—
—
0
0
320
1611
2.18
32.16
2.6
3.8
8.3
27.2
ug/l
2.21
293
1363
224
4516
0.43
31.46
2.8
3.3
0.8
0.9
ug/l
1.42
149
3240
416
2329
2.00
31.39
3.9
2.9
0.8
0.8
mmol/l
10.59
404
2142
933
11854
0.59
27.70
32.7
19.2
43.4
30.4
mg/l
21.12
898
9922
59
126
4.80
26.02
1.3
1.3
—
—
—
0
0
111
2804
0.36
25.70
1.6
1.6
1.5
1.3
mmol/l
1.83
94
2279
759
9946
0.61
23.41
30.1
20.5
37.7
37.9
%
0.16
449
5749
97
335
2.99
21.42
1.4
1.5
37.2
29.8
g/l
8.58
89
300
288
4735
0.54
20.37
1.8
2.1
75.0
78.1
nmol/l
1.00
250
4043
699
9146
0.63
19.88
36.6
23.1
14.8
14.1
%
28.82
685
8857
206
3712
0.50
19.44
1.4
1.6
18.5
19.1
nmol/l
0.26
175
3165
35
61
5.82
19.33
1.2
1.3
18.0
25.6
iu/l
0.75
25
52
80
270
3.05
18.40
1.4
1.4
15469.2
61894.6
e6/l
2.13
51
163
327
5064
0.57
18.24
2.5
2.9
250.0
177.1
ug/l
2.98
294
4512
84
293
2.95
18.24
1.4
1.5
1626.3
1980.1
e6/l
0.35
63
211
614
8137
0.64
17.63
5.0
3.4
15.4
15.1
pmol/l
1.41
557
7071
319
1962
1.75
16.95
4.3
3.7
222.7
248.1
u/l
3.38
309
1819
421
6028
0.62
16.83
3.9
4.0
0.0
0.0
estimate
0.00
96
1104
59
175
3.45
16.77
1.2
1.3
9.3
15.6
u/l
1.73
59
163
62
194
3.27
16.21
2.7
3.7
—
—
—
0
0
267
4222
0.57
15.64
2.8
3.2
7.4
7.5
mmol/l
0.15
201
3436
421
5953
0.63
15.63
3.9
3.9
0.0
0.0
estimate
0.00
100
1147
291
4495
0.59
15.57
3.6
4.0
13.2
10.6
mg/mmol
0.35
184
2974
419
5921
0.63
15.47
5.2
5.3
0.0
0.0
estimate
0.00
102
1140
53
159
3.40
14.83
1.3
1.4
11.4
14.3
u/l
3.04
53
147
224
3669
0.56
14.81
2.6
3.0
368.4
7421.0
umol/l
13.04
177
3066
707
8766
0.70
12.68
4.4
4.9
161.6
2413.7
e6/l
2.16
17
197
319
4626
0.63
12.64
4.3
4.3
—
—
—
0
0
146
788
1.92
11.75
2.0
1.8
1.3
2.9
ug/l
1.04
131
678
204
3244
0.59
11.73
1.6
1.8
437.2
16149245.7
pmol/l
1.68
172
2607
284
4096
0.64
10.67
2.1
2.3
3.5
3.1
mg/l
1.12
244
3415
79
352
2.30
10.55
1.3
1.6
—
—
—
0
0
75
329
2.33
10.38
1.3
1.7
—
—
—
0
0
49
175
2.85
10.31
1.6
1.6
2.4
5.5
iu/l
2.07
12
47
56
222
2.57
9.66
3.2
3.0
6.0
4.7
e9/l
2.92
56
222
61
253
2.46
9.58
1.3
1.7
—
—
—
0
0
56
233
2.44
8.76
3.6
3.4
65.8
60.4
%
2.44
56
233
52
209
2.53
8.75
1.3
1.6
—
—
—
0
0
543
6752
0.73
8.69
4.6
3.2
67.7
61.1
u/l
0.43
507
6072
105
1847
0.54
8.55
1.2
1.2
2.1
1.6
u/ml
0.17
26
452
37
126
2.97
8.52
1.2
1.7
281.1
283.9
mu/l
0.03
37
118
248
3521
0.66
8.37
1.8
1.9
1031.5
1150.0
nmol/l
1.32
189
2598
38
135
2.85
8.13
1.1
1.7
—
—
—
0
0
38
142
2.71
7.43
1.1
1.7
—
—
—
0
0
183
2704
0.64
7.40
4.6
4.4
1.0
1.0
kg/l
0.48
31
439
391
5020
0.72
7.39
2.5
2.2
—
—
—
0
0
244
3394
0.68
7.31
4.2
4.3
0.0
0.0
estimate
0.42
82
1039
144
902
1.64
7.03
5.9
6.9
25.6
24.5
mmol/l
2.78
144
890
29
97
3.02
6.93
1.3
1.6
66.5
69.5
%
0.18
24
74
155
993
1.61
6.91
1.6
1.5
—
—
—
0
0
769
8915
0.77
6.90
5.7
4.1
26.0
15.3
mm/h
28.61
731
8057
270
1950
1.45
6.88
6.3
6.4
1.8
1.1
mmol/l
2.46
224
1470
99
1660
0.57
6.77
3.3
4.8
33.5
33.0
%
0.19
67
1082
269
1948
1.44
6.75
6.3
6.4
5.4
5.0
kpa
4.14
257
1831
269
1948
1.44
6.75
6.3
6.4
10.3
11.5
kpa
5.49
258
1834
30
104
2.91
6.75
2.9
3.5
—
—
—
0
0
98
579
1.73
5.98
1.9
2.1
210.6
691.4
ug/l
2.53
90
547
807
6980
1.27
5.94
15.1
8.2
5.3
4.5
e9/l
10.23
741
6017
138
901
1.57
5.72
5.5
8.1
24.7
24.2
mmol/l
1.39
132
823
50
240
2.11
5.71
1.4
1.5
—
—
—
0
0
351
2754
1.33
5.38
2.0
1.9
—
—
—
0
0
155
2216
0.67
5.27
2.1
2.7
17.2
22.1
%
5.58
130
1863
45
216
2.11
5.17
1.5
1.5
—
—
—
0
0
38
171
2.25
5.11
1.3
1.7
—
—
—
0
0
165
2317
0.69
5.09
2.1
2.6
2.1
2.2
g/l
0.36
155
2109
115
1727
0.65
4.97
13.8
9.3
—
—
—
0
0
182
2499
0.70
4.96
2.1
2.7
9.1
11.9
umol/l
8.99
173
2275
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
108
690
1.60
4.94
2.2
2.5
0.3
0.3
u/ml
3.71
63
389
31
131
2.39
4.82
1.1
1.6
—
—
—
0
0
31
131
2.39
4.82
1.1
1.6
—
—
—
0
0
31
131
2.39
4.82
1.1
1.6
—
—
—
0
0
42
203
2.09
4.76
1.5
1.5
—
—
—
0
0
208
1545
1.39
4.52
7.3
7.2
120.6
120.1
g/l
0.15
202
1492
500
5889
0.80
4.51
4.8
4.5
45.0
102.2
ng/l
1.19
424
4725
40
194
2.08
4.51
1.5
1.5
—
—
—
0
0
14
39
3.61
4.48
1.4
1.9
2.2
3.2
%
—
9
17
65
382
1.73
4.14
5.6
5.1
5.2
5.0
kpa
1.14
65
371
35
685
0.50
4.11
2.1
2.4
8.5
7.4
g/l
2.30
27
484
35
684
0.50
4.09
2.1
2.4
—
—
—
0
0
35
684
0.50
4.09
2.1
2.4
4.5
3.8
g/l
0.57
27
467
243
1881
1.33
4.07
1.8
1.9
—
—
—
0
0
243
1887
1.33
3.98
1.8
1.8
—
—
—
0
0
5
208
0.24
3.97
1.0
1.1
—
17.2
—
0
10
896
9847
0.83
3.84
14.2
7.6
86.0
83.8
u/l
0.59
876
9137
25
107
2.35
3.83
1.3
1.7
—
—
—
0
0
95
1401
0.66
3.80
1.2
1.2
23.1
15.9
u/ml
0.22
21
467
729
6464
1.20
3.75
7.5
6.1
1.2
1.2
mmol/l
8.97
694
5765
59
951
0.61
3.54
3.4
3.0
0.6
0.3
e6/l
0.56
59
934
33
624
0.52
3.52
2.2
2.5
3.4
3.1
g/l
0.93
27
478
13
349
0.37
3.46
1.3
1.8
—
—
—
0
0
466
5404
0.82
3.45
3.3
3.6
—
—
—
0
0
69
1063
0.64
3.41
2.0
2.1
11.0
11.7
nmol/l
0.29
58
896
35
642
0.54
3.39
2.1
2.5
9.8
10.5
g/l
0.57
28
533
19
76
2.51
3.38
1.5
2.1
—
—
—
0
0
204
2596
0.76
3.38
26.2
30.4
1.4
1.6
inr
0.62
32
356
336
2781
1.25
3.35
5.5
3.1
2.5
2.5
mmol/l
19.71
309
2381
57
913
0.61
3.34
1.5
1.7
1.9
1.5
g/l
2.14
47
765
21
89
2.37
3.32
1.7
1.6
—
—
—
0
0
145
1078
1.37
3.19
3.9
3.8
2.4
1.9
mmol/l
1.17
121
777
63
398
1.60
3.13
1.3
1.4
—
—
—
0
0
63
398
1.60
3.13
1.3
1.4
—
—
—
0
0
151
1137
1.36
3.08
4.0
3.8
5.4
5.1
kpa
2.48
142
1043
20
88
2.29
2.94
1.8
1.6
—
—
—
0
0
110
1500
0.72
2.91
1.2
1.2
74.1
41.5
iu/ml
0.55
24
469
23
108
2.14
2.91
1.7
1.5
—
—
—
0
0
454
5199
0.83
2.86
3.0
3.3
1484.7
2294.6
ng/l
6.96
415
4502
29
152
1.92
2.75
1.0
1.5
—
—
—
0
0
26
132
1.98
2.70
1.5
1.7
—
—
—
0
0
426
3692
1.20
2.69
4.7
3.0
29.2
35.5
u/l
2.90
414
3486
29
154
1.90
2.66
1.0
1.5
—
—
—
0
0
7
202
0.34
2.65
1.0
1.1
—
—
—
0
0
36
606
0.59
2.64
1.6
3.3
28.8
78.1
mg/l
1.51
25
489
36
606
0.59
2.64
1.6
3.3
73.0
71.4
mg/l
0.03
25
484
769
7007
1.16
2.63
10.5
6.0
9.5
13.2
umol/l
12.27
751
6605
29
155
1.88
2.61
1.0
1.5
—
—
—
0
0
35
592
0.58
2.61
1.6
3.3
—
2.0
—
0
46
6
182
0.33
2.52
1.2
1.2
—
—
—
0
0
68
463
1.49
2.48
1.4
1.7
—
—
—
0
0
79
1101
0.71
2.42
2.8
4.0
68.6
103.5
ng/l
4.24
65
927
9
224
0.40
2.42
1.1
1.3
—
—
—
0
0
10
34
2.95
2.41
1.2
1.2
—
—
—
0
0
774
7090
1.15
2.41
8.0
7.0
1.2
1.2
mmol/l
8.05
665
5885
58
385
1.52
2.40
2.1
2.3
121.8
126.7
g/l
0.68
32
279
382
3312
1.19
2.39
2.5
2.6
—
—
—
0
0
11
265
0.41
2.38
1.6
1.2
665.5
589.7
mg/l
0.24
11
247
16
333
0.48
2.37
1.0
1.0
—
—
—
0
0
28
155
1.82
2.30
1.0
1.5
—
—
—
0
0
28
156
1.81
2.26
1.0
1.5
—
—
—
0
0
28
156
1.81
2.26
1.0
1.5
—
—
—
0
0
0
62
0.00
2.22
0.0
1.2
—
—
—
0
0
0
62
0.00
2.22
0.0
1.2
—
—
—
0
0
13
284
0.45
2.22
1.8
1.5
—
—
—
0
0
137
1072
1.30
2.21
9.8
6.4
25.7
24.3
mmol/l
3.69
130
1006
44
284
1.56
2.09
2.4
3.8
1.4
1.6
%
0.15
38
217
28
470
0.59
2.09
1.5
1.6
—
—
—
0
0
177
1442
1.25
2.08
5.1
6.1
1.4
1.5
mmol/l
0.48
171
1363
407
4589
0.86
2.06
3.2
3.6
107.0
114.6
e6/l
0.06
343
3686
71
508
1.41
2.05
6.6
4.0
4.0
4.0
mmol/l
0.40
65
461
182
2191
0.81
1.92
2.4
2.3
1.7
1.8
%
0.16
156
1911
87
662
1.33
1.76
4.8
4.2
25.7
24.8
mmol/l
1.75
82
605
18
95
1.90
1.75
3.2
3.3
—
—
—
0
0
11
228
0.48
1.68
1.5
1.2
3.9
4.0
mmol/l
0.11
11
205
214
2496
0.84
1.64
2.9
3.0
0.8
1.1
e6/l
1.10
129
1519
6
146
0.41
1.64
1.7
1.5
—
—
—
0
0
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
10
43
2.33
1.60
1.0
1.4
—
—
—
0
0
389
4317
0.88
1.55
2.1
2.2
170.8
263.1
u/l
1.90
370
4002
5
15
3.34
1.52
1.2
1.1
—
—
—
0
0
7
27
2.60
1.51
1.1
2.7
—
—
—
0
0
15
79
1.91
1.49
1.3
1.6
—
—
—
0
0
15
79
1.91
1.49
1.3
1.6
—
—
—
0
0
15
79
1.91
1.49
1.3
1.6
—
—
—
0
0
15
79
1.91
1.49
1.3
1.6
—
—
—
0
0
9
37
2.44
1.48
1.2
1.8
—
—
—
0
0
66
498
1.34
1.46
3.0
3.4
25.6
24.8
mmol/l
0.79
56
437
50
363
1.39
1.41
3.0
2.8
14.7
15.6
%
0.82
25
183
27
173
1.57
1.40
1.7
3.8
55.5
57.9
%
0.24
21
110
233
2032
1.17
1.40
6.8
6.4
103.3
104.4
mmol/l
2.76
225
1972
57
424
1.35
1.39
1.2
1.1
52.6
137.1
iu/ml
1.64
11
140
0
39
0.00
1.33
0.0
1.2
—
—
—
0
0
5
18
2.78
1.28
6.0
16.5
2609.6
1488.9
nmol/l
—
5
18
32
459
0.69
1.27
1.5
1.3
—
—
—
0
0
495
4566
1.11
1.26
5.1
3.2
2.4
2.3
mmol/l
8.60
460
3850
21
328
0.64
1.26
1.0
1.5
188.3
260.1
ug/g
1.05
12
212
127
1511
0.83
1.26
2.0
2.7
6.8
11.6
umol/l
1.96
109
1331
213
2419
0.87
1.21
2.9
3.3
3.2
1.3
e6/l
1.12
128
1449
82
657
1.26
1.21
2.0
1.9
—
—
—
0
0
28
407
0.68
1.20
4.2
3.8
1.8
1.7
mmol/l
0.13
28
399
294
3266
0.88
1.20
2.5
2.8
5.5
3.7
e6/l
2.03
265
2894
11
199
0.55
1.17
2.4
1.6
—
—
—
0
0
11
57
1.94
1.17
2.5
2.6
—
—
—
0
0
11
57
1.94
1.17
2.5
2.6
—
—
—
0
0
61
473
1.30
1.16
5.5
3.2
4.4
4.3
pmol/l
0.31
56
405
10
50
2.01
1.16
1.1
1.7
—
—
—
0
0
42
565
0.74
1.16
2.1
3.0
24.5
7703.6
u/ml
0.92
33
478
77
616
1.26
1.16
6.2
3.8
1.3
1.5
mmol/l
1.20
77
606
14
235
0.59
1.15
1.2
1.3
—
—
—
0
0
11
58
1.90
1.12
1.5
1.2
29.8
22.1
%
0.34
11
43
13
218
0.59
1.07
1.2
1.3
—
—
—
0
0
88
723
1.23
1.06
2.1
2.0
—
—
—
0
0
27
384
0.70
1.06
1.3
1.2
—
—
—
0
0
72
888
0.80
1.05
1.5
1.7
1.9
1.7
%
0.65
54
707
773
8115
0.92
1.02
6.8
5.0
6.9
7.0
mmol/l
0.32
753
7652
32
230
1.40
1.01
2.3
2.0
86.5
88.7
%
0.55
32
230
27
379
0.71
1.00
4.3
3.9
7.0
7.8
mmol/l
1.92
27
371
26
367
0.70
0.99
1.2
1.3
—
—
—
0
0
137
1579
0.86
0.98
2.8
3.1
176.9
303.9
ng/l
6.22
128
1448
0
29
0.00
0.97
0.0
1.0
—
—
—
0
0
378
4089
0.91
0.97
3.0
3.5
0.7
0.5
e6/l
0.51
312
3221
20
295
0.67
0.97
1.5
1.3
1.2
1.1
g/l
0.12
20
281
23
329
0.70
0.95
1.2
1.2
—
—
—
0
0
23
327
0.70
0.92
1.2
1.2
—
—
—
0
0
140
1602
0.86
0.92
4.9
3.9
—
—
—
0
0
11
182
0.60
0.89
2.0
2.2
3.1
246.0
u/ml
0.58
11
177
67
810
0.82
0.85
4.4
4.2
50.4
46.8
%
0.66
67
798
20
285
0.70
0.83
1.4
1.3
0.2
0.2
g/l
0.60
20
271
8
139
0.57
0.83
1.0
1.0
—
—
—
0
0
0
24
0.00
0.79
0.0
2.5
—
—
—
0
0
6
33
1.82
0.79
3.5
1.7
—
—
—
0
0
0
25
0.00
0.79
0.0
2.4
—
—
—
0
0
0
26
0.00
0.78
0.0
1.0
—
1569.9
—
0
26
35
451
0.77
0.78
1.2
1.7
34.6
37.8
u/l
0.44
30
378
116
1324
0.87
0.77
3.2
3.0
4.6
4.4
kpa
0.38
110
1258
10
161
0.62
0.75
1.5
1.9
1.0
2.0
u/field
—
5
55
571
5999
0.93
0.73
4.4
4.6
—
—
—
0
0
9
55
1.64
0.73
1.2
1.7
—
—
—
0
0
9
55
1.64
0.73
1.2
1.7
—
—
—
0
0
15
100
1.50
0.73
1.1
1.4
—
—
—
0
0
441
4158
1.08
0.71
5.0
2.5
56.0
58.8
u/l
0.69
424
3807
30
229
1.31
0.71
8.9
8.4
7.1
7.5
mmol/l
0.26
24
190
15
101
1.49
0.70
1.1
1.4
—
—
—
0
0
9
58
1.55
0.69
1.2
1.7
—
—
—
0
0
36
286
1.26
0.65
1.3
1.6
—
—
—
0
0
11
70
1.57
0.65
2.7
2.9
189.5
209.9
u/l
0.53
11
70
11
70
1.57
0.65
1.0
1.4
—
—
—
0
0
11
70
1.57
0.65
1.0
1.4
—
—
—
0
0
33
416
0.79
0.65
2.3
2.4
87.3
92.3
ug/min
0.04
17
248
14
201
0.69
0.64
1.3
1.2
—
—
—
0
0
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
132
1182
1.13
0.63
4.2
4.0
1.2
1.2
mmol/l
2.93
124
1019
44
535
0.82
0.63
1.1
1.2
—
—
—
0
0
29
368
0.78
0.61
4.0
3.9
48.3
31.7
mg/l
1.09
23
252
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
18
243
0.74
0.59
1.1
1.3
1.8
0.8
nmol/l
0.61
12
196
192
2087
0.91
0.59
4.6
5.6
1.0
1.0
mmol/l
2.32
182
1894
11
72
1.53
0.59
1.2
1.1
125.5
118.6
u/l
0.05
11
62
35
282
1.25
0.58
2.3
2.1
1.7
1.7
mmol/l
0.20
35
276
26
331
0.78
0.57
1.3
1.6
83356.7
17672.7
e6/l
0.61
19
236
9
61
1.48
0.53
1.2
2.5
—
—
—
0
0
9
62
1.45
0.53
1.7
1.3
—
—
—
0
0
147
1605
0.91
0.51
3.1
3.6
6.1
5.8
kpa
1.88
142
1537
117
1058
1.11
0.51
1.6
1.7
—
—
—
0
0
32
261
1.23
0.50
1.2
1.4
—
—
—
0
0
7
45
1.56
0.49
2.9
2.8
—
—
—
0
0
147
1598
0.91
0.48
3.1
3.7
2.8
1.9
mmol/l
2.14
126
1230
7
47
1.49
0.47
1.3
1.8
12.4
15.5
nmol/l
—
7
41
168
1554
1.09
0.47
3.5
6.7
9.3
12.3
mmol/l
5.59
158
1448
5
81
0.62
0.45
2.0
1.5
5.0
10.5
u/l
—
5
40
5
83
0.60
0.45
1.0
1.1
—
—
—
0
0
78
871
0.89
0.43
3.8
3.6
27.0
24.9
mmol/l
4.77
78
846
9
127
0.71
0.43
1.0
1.1
—
—
—
0
0
5
32
1.56
0.42
1.2
1.0
—
—
—
0
0
5
32
1.56
0.42
1.2
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
15.0
—
0
9
0
15
0.00
0.41
0.0
1.3
—
16.6
—
0
15
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
7
101
0.69
0.39
1.0
1.1
—
—
—
0
0
147
1574
0.93
0.36
2.2
2.6
6.1
6.7
ug/l
0.16
130
1335
28
330
0.85
0.34
1.9
2.5
41.0
32.7
umol/l
0.77
22
276
24
286
0.84
0.33
1.7
1.7
—
—
—
0
0
18
221
0.81
0.33
3.0
2.3
36.1
21.9
mg/l
—
8
46
20
164
1.22
0.32
2.4
2.7
—
—
—
0
0
10
74
1.35
0.32
2.7
1.8
338.8
666.2
e6/l
—
5
32
632
6169
1.04
0.30
5.8
4.8
31.8
33.9
g/l
14.02
603
5623
124
1321
0.93
0.29
1.7
2.1
0.2
0.2
g/l
0.33
116
1207
8
108
0.74
0.29
1.8
1.3
—
—
—
0
0
10
76
1.32
0.28
1.0
1.3
—
—
—
0
0
110
1174
0.93
0.27
2.8
2.4
35.0
36.9
u/l
0.10
99
973
139
1464
0.95
0.24
1.7
2.6
65.6
65.7
g/l
0.04
128
1309
6
81
0.74
0.24
2.0
1.2
—
—
—
0
0
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
7
94
0.74
0.22
1.0
1.1
124.0
110.0
%
—
7
86
0
11
0.00
0.21
0.0
1.5
—
92.9
—
0
11
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.1
—
81.0
—
0
6
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
81.0
—
0
5
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
5.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
2.7
—
109.1
—
0
14
21
239
0.88
0.19
1.3
1.2
3.4
2.9
u/ml
—
7
31
14
164
0.85
0.18
1.2
1.4
73.8
65.9
%
—
9
107
119
1137
1.05
0.18
1.5
1.6
—
—
—
0
0
22
247
0.89
0.17
3.0
2.9
4.2
4.1
mmol/l
0.18
22
242
22
247
0.89
0.17
3.0
2.9
105.5
105.8
mmol/l
0.08
22
242
10
119
0.84
0.15
1.8
1.3
—
—
—
0
0
9
82
1.10
0.15
1.4
2.1
—
—
—
0
0
11
127
0.87
0.12
1.0
1.2
—
0.5
nmol/l
—
0
7
34
317
1.07
0.12
1.6
1.5
3.8
16.7
iu/ml
—
8
76
94
906
1.04
0.11
1.3
1.2
—
—
—
0
0
80
770
1.04
0.10
3.0
2.6
1.6
1.1
%
2.82
80
764
5
45
1.11
0.09
1.0
1.2
117.0
223.4
iu/ml
—
5
45
7
65
1.08
0.08
1.3
1.0
—
—
—
0
0
19
205
0.93
0.08
1.0
1.1
—
—
—
0
0
6
72
0.83
0.07
1.3
1.0
—
—
—
0
0
6
75
0.80
0.07
1.0
1.1
95.3
96.3
%
—
6
70
299
2954
1.01
0.07
5.0
4.2
268.8
437.8
ng/l
0.45
265
2632
21
197
1.07
0.06
1.2
1.4
—
—
—
0
0
248
2507
0.99
0.05
1.5
1.6
1.3
1.7
mg/l
1.40
206
1987
20
189
1.06
0.04
1.3
2.4
—
1878.3
u/ml
—
0
20
12
130
0.92
0.04
1.2
1.4
—
—
—
0
0
74
752
0.98
0.03
3.0
2.6
0.7
0.7
%
0.54
74
722
103
1018
1.01
0.02
5.8
3.1
62.8
57.8
ml/min/173m2
0.79
41
452
10
107
0.93
0.02
1.0
1.1
—
—
—
0
0
31
316
0.98
0.00
1.4
2.1
88.9
84.7
%
0.37
31
301
43
425
1.01
0.00
2.8
3.0
0.8
0.9
nmol/l
0.44
37
318
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
5.0
—
382.0
—
0
5
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
5
55
0.91
0.00
1.0
1.2
—
—
—
0
0
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
9
93
0.97
0.00
2.1
2.4
—
—
—
0
0
5
55
0.91
0.00
1.2
1.4
—
—
—
0
0
8
88
0.91
0.00
1.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
85.9
—
0
8
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
18.8
—
0
6
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
24.7
—
0
7
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
5
56
0.89
0.00
1.0
1.4
5.4
9.4
u/l
—
5
44
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
6.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
65
0.92
0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
6.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_NSCLC_SQUAM – Non-small cell lung cancer, squamous
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).